Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Li H, Yang F, Hu A, Wang X, Fang E, Chen Y, Li D, Song H, Wang J, Guo Y, Liu Y, Li H, Huang K, Zheng L, Tong Q.
Li H, et al. Among authors: wang x, wang j.
EMBO Mol Med. 2019 Dec;11(12):e10835. doi: 10.15252/emmm.201910835. Epub 2019 Nov 11.
EMBO Mol Med. 2019.
PMID: 31709724
Free PMC article.